Hologic Company Profile (NASDAQ:HOLX)

About Hologic (NASDAQ:HOLX)

Hologic logoHologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:HOLX
  • CUSIP: 43644010
  • Web: www.hologic.com
  • Market Cap: $12.18 billion
  • Outstanding Shares: 280,010,000
Average Prices:
  • 50 Day Moving Avg: $43.70
  • 200 Day Moving Avg: $41.06
  • 52 Week Range: $32.64 - $46.05
  • Trailing P/E Ratio: 15.60
  • Foreward P/E Ratio: 19.68
  • P/E Growth: 2.18
Sales & Book Value:
  • Annual Revenue: $2.89 billion
  • Price / Sales: 4.21
  • Book Value: $10.00 per share
  • Price / Book: 4.35
  • EBIDTA: $1.01 billion
  • Net Margins: 11.57%
  • Return on Equity: 27.17%
  • Return on Assets: 7.86%
  • Debt-to-Equity Ratio: 1.17%
  • Current Ratio: 1.81%
  • Quick Ratio: 1.61%
  • Average Volume: 2.47 million shs.
  • Beta: 1.1
  • Short Ratio: 2.09

Frequently Asked Questions for Hologic (NASDAQ:HOLX)

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) issued its quarterly earnings data on Wednesday, May, 10th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.46 by $0.04. The business had revenue of $715.40 million for the quarter, compared to analyst estimates of $685.24 million. Hologic had a return on equity of 27.17% and a net margin of 11.57%. Hologic's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.47 EPS. View Hologic's Earnings History.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its FY17 earnings guidance on Wednesday, May, 10th. The company provided earnings per share guidance of $1.98-2.02 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.98. The company issued revenue guidance of $3.05-3.08 billion, compared to the consensus revenue estimate of $3.06 billion.Hologic also updated its Q3 guidance to $0.48-0.50 EPS.

Where is Hologic's stock going? Where will Hologic's stock price be in 2017?

13 analysts have issued 1 year price objectives for Hologic's stock. Their forecasts range from $39.00 to $53.00. On average, they expect Hologic's share price to reach $47.42 in the next year. View Analyst Ratings for Hologic.

What are analysts saying about Hologic stock?

Here are some recent quotes from research analysts about Hologic stock:

  • 1. According to Zacks Investment Research, "Hologic posted better-than-expected results in the second quarter of fiscal 2017, with both earnings and sales beating the Zacks Consensus Estimate. The company’s top-line growth was driven by strength in molecular diagnostics, GYN Surgical and Breast Health businesses. Management’s raised guidance for fiscal 2017 also raises optimism. For the last three months, Hologic has been trading above the broader Medical Instruments industry in terms of price. Post the earnings release, the company’s share price scaled higher. Hologic’s strong cash position is another encouraging factor. However, we are disappointed with the sales decline at the company’s Diagnostics segment. The blood screening divestiture is expected to impede the company’s growth momentum in the days ahead. Foreign currency headwinds and a competitive landscape also continue to pose challenges." (5/23/2017)
  • 2. Needham & Company LLC analysts commented, "HOLX is acquiring Cynosure (CYNO) for $1.44B with an all-cash tender offer. CYNO is a leading aesthetics company that competes in a $2B market growing in the double-digits with a range of products used for hair removal, body contouring, skin revitalization, and other cosmetic procedures. HOLX expects CYNO to increase its revenue growth and add $0.13-0.15 to its FY18E EPS. HOLX has now effectively swapped a business with declining sales and margins (blood screening) for one with double-digit growth and improving margins (CYNO). With the blood screening EPS "hole" now partially filled and HOLX facing increasingly easy comps over the next three quarters, we upgrade to Buy." (2/15/2017)

Are investors shorting Hologic?

Hologic saw a increase in short interest in the month of April. As of April 28th, there was short interest totalling 5,758,843 shares, an increase of 25.2% from the April 13th total of 4,599,454 shares. Based on an average daily volume of 2,303,808 shares, the short-interest ratio is presently 2.5 days.

Who are some of Hologic's key competitors?

Who owns Hologic stock?

Hologic's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (10.15%), State Street Corp (4.54%), Victory Capital Management Inc. (1.45%), Bank of Montreal Can (1.15%), American Century Companies Inc. (1.13%) and Geode Capital Management LLC (1.12%). Company insiders that own Hologic stock include David R Lavance Jr, Elaine Ullian, Karleen Marie Oberton, Lawrence M Levy, Nancy Leaming, Peter J Valenti III, Sally Crawford and Wayne Wilson. View Institutional Ownership Trends for Hologic.

Who sold Hologic stock? Who is selling Hologic stock?

Hologic's stock was sold by a variety of institutional investors in the last quarter, including Nomura Holdings Inc., Prudential Financial Inc., Old Mutual Global Investors UK Ltd., UBS Asset Management Americas Inc., Schwab Charles Investment Management Inc., Vanguard Group Inc., Cornerstone Capital Management Holdings LLC. and Kahn Brothers Group Inc. DE. Company insiders that have sold Hologic stock in the last year include Elaine Ullian, Karleen Marie Oberton, Lawrence M Levy, Nancy Leaming, Peter J Valenti III and Sally Crawford. View Insider Buying and Selling for Hologic.

Who bought Hologic stock? Who is buying Hologic stock?

Hologic's stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., American Century Companies Inc., Bank of Montreal Can, Pictet Asset Management Ltd., Quantitative Investment Management LLC, Neuberger Berman Group LLC, Canada Pension Plan Investment Board and TD Asset Management Inc.. View Insider Buying and Selling for Hologic.

How do I buy Hologic stock?

Shares of Hologic can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Hologic stock cost?

One share of Hologic stock can currently be purchased for approximately $43.50.

Analyst Ratings

Consensus Ratings for Hologic (NASDAQ:HOLX) (?)
Ratings Breakdown: 4 Hold Ratings, 9 Buy Ratings
Consensus Rating:Buy (Score: 2.69)
Consensus Price Target: $47.42 (9.00% upside)

Analysts' Ratings History for Hologic (NASDAQ:HOLX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/14/2017BTIG ResearchReiterated RatingBuy$47.00LowView Rating Details
5/11/2017Stifel NicolausBoost Price TargetBuy -> Buy$45.00 -> $48.00HighView Rating Details
5/9/2017Canaccord GenuityReiterated RatingBuy$53.00LowView Rating Details
4/5/2017Barclays PLCSet Price TargetBuy$50.00LowView Rating Details
4/4/2017Needham & Company LLCBoost Price TargetBuy -> Buy$46.00 -> $50.00MediumView Rating Details
3/30/2017Leerink SwannReiterated RatingOutperform$52.00LowView Rating Details
3/14/2017Piper Jaffray CompaniesReiterated RatingOverweight$51.00LowView Rating Details
3/13/2017Jefferies Group LLCReiterated RatingBuy$46.00 -> $49.00LowView Rating Details
2/15/2017Bank of America CorpDowngradeBuy -> NeutralN/AView Rating Details
1/18/2017Deutsche Bank AGReiterated RatingBuy$48.00N/AView Rating Details
1/4/2017Evercore ISIDowngradeBuy -> Hold$42.00N/AView Rating Details
8/1/2016Royal Bank of CanadaReiterated RatingSector Perform$37.00 -> $39.00N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetEqual Weight$38.00 -> $40.00N/AView Rating Details
4/29/2016Goldman Sachs Group IncReiterated RatingConviction-Buy -> Buy$45.00N/AView Rating Details
1/31/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/28/2016JPMorgan Chase & Co.Reiterated RatingBuyN/AView Rating Details
10/26/2015GabelliInitiated CoverageBuy$43.00N/AView Rating Details
10/21/2015Craig HallumDowngradeBuy -> Hold$42.00 -> $37.00N/AView Rating Details
8/3/2015ArgusReiterated RatingBuy$43.00 -> $52.00N/AView Rating Details
7/13/2015Evercore Partners Inc.Reiterated RatingBuy -> HoldN/AView Rating Details
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$35.00 -> $40.00N/AView Rating Details
(Data available from 5/26/2015 forward)


Earnings History for Hologic (NASDAQ:HOLX)
Earnings by Quarter for Hologic (NASDAQ:HOLX)
Earnings History by Quarter for Hologic (NASDAQ:HOLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/2017Q2 17$0.46$0.50$685.24 million$715.40 millionViewN/AView Earnings Details
2/1/2017Q117$0.51$0.52$725.01 million$734.40 millionViewListenView Earnings Details
11/2/2016Q416$0.50$0.52$721.52 million$726.80 millionViewN/AView Earnings Details
7/27/2016Q316$0.48$0.51$703.66 million$717.40 millionViewListenView Earnings Details
4/27/2016Q216$0.46$0.47$686.82 million$693.30 millionViewListenView Earnings Details
1/27/2016Q116$0.42$0.46$688.68 million$695.20 millionViewListenView Earnings Details
11/4/2015Q415$0.42$0.43$691.94 million$702.80 millionViewListenView Earnings Details
7/29/2015Q315$0.39$0.43$653.85 million$693.90 millionViewListenView Earnings Details
4/29/2015Q215$0.39$0.41$646.49 million$655.50 millionViewN/AView Earnings Details
1/28/2015Q115$0.36$0.39$630.79 million$652.80 millionViewListenView Earnings Details
11/5/2014Q414$0.37$0.43$636.20 million$660.60 millionViewListenView Earnings Details
7/30/2014Q314$0.34$0.37$621.89 million$632.60 millionViewListenView Earnings Details
4/30/2014Q214$0.33$0.37$609.35 million$625.00 millionViewListenView Earnings Details
2/3/2014Q114$0.31$0.34$609.65 million$612.40 millionViewListenView Earnings Details
11/11/2013Q413$0.37$0.39$624.40 million$622.10 millionViewListenView Earnings Details
8/5/2013Q3 2013$0.37$0.38$627.05 million$626.10 millionViewListenView Earnings Details
5/6/2013Q2 2013$0.34$0.35$639.53 million$619.10 millionViewListenView Earnings Details
2/4/2013Q1 2013$0.37$0.38$646.52 million$644.60 millionViewListenView Earnings Details
11/12/2012Q412$0.36$0.37$581.12 million$600.20 millionViewN/AView Earnings Details
7/30/2012$0.34$0.35ViewN/AView Earnings Details
4/30/2012$0.33$0.33ViewN/AView Earnings Details
1/30/2012$0.32$0.34ViewN/AView Earnings Details
11/7/2011$0.33$0.34ViewN/AView Earnings Details
8/1/2011$0.32$0.32ViewN/AView Earnings Details
5/2/2011$0.28$0.30ViewN/AView Earnings Details
1/31/2011$0.28$0.30ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Hologic (NASDAQ:HOLX)
2017 EPS Consensus Estimate: $2.01
2018 EPS Consensus Estimate: $2.33
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$0.50$0.51$0.51
Q2 20173$0.46$0.53$0.49
Q3 20173$0.48$0.54$0.50
Q4 20173$0.49$0.55$0.52
Q1 20181$0.54$0.54$0.54
Q2 20181$0.57$0.57$0.57
Q3 20181$0.60$0.60$0.60
Q4 20181$0.62$0.62$0.62
(Data provided by Zacks Investment Research)


Dividend History for Hologic (NASDAQ:HOLX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Hologic (NASDAQ:HOLX)
Insider Ownership Percentage: 0.79%
Institutional Ownership Percentage: 94.09%
Insider Trades by Quarter for Hologic (NASDAQ:HOLX)
Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)
Insider Trades by Quarter for Hologic (NASDAQ:HOLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/17/2017Lawrence M LevyDirectorSell9,076$42.80$388,452.80View SEC Filing  
5/10/2017Lawrence M LevyDirectorSell9,837$45.34$446,009.58View SEC Filing  
5/3/2017Lawrence M LevyDirectorSell10,203$45.00$459,135.00View SEC Filing  
4/26/2017Lawrence M LevyDirectorSell10,374$44.46$461,228.04View SEC Filing  
4/24/2017Sally CrawfordDirectorSell16,969$44.00$746,636.00View SEC Filing  
4/19/2017Lawrence M LevyDirectorSell10,836$42.49$460,421.64View SEC Filing  
4/12/2017Lawrence M LevyDirectorSell10,757$42.45$456,634.65View SEC Filing  
4/3/2017Elaine UllianDirectorSell9,104$42.40$386,009.60View SEC Filing  
3/8/2017Sally CrawfordDirectorSell17,396$42.00$730,632.00View SEC Filing  
2/3/2017Elaine UllianDirectorSell9,423$39.54$372,585.42View SEC Filing  
11/21/2016Karleen Marie ObertonVPSell3,023$38.32$115,841.36View SEC Filing  
11/15/2016Karleen Marie ObertonVPSell1,211$36.55$44,262.05View SEC Filing  
11/8/2016Karleen Marie ObertonVPSell984$38.57$37,952.88View SEC Filing  
11/7/2016Karleen Marie ObertonVPSell522$38.53$20,112.66View SEC Filing  
10/10/2016Elaine UllianDirectorSell18,236$39.88$727,251.68View SEC Filing  
10/10/2016Karleen Marie ObertonVPSell31,470$40.00$1,258,800.00View SEC Filing  
7/21/2016Nancy LeamingDirectorSell8,179$37.00$302,623.00View SEC Filing  
7/11/2016Nancy LeamingDirectorSell6,221$36.04$224,204.84View SEC Filing  
6/1/2016Lawrence M LevyDirectorSell17,794$34.41$612,291.54View SEC Filing  
5/27/2016Peter J Valenti IIIInsiderSell10,022$33.83$339,044.26View SEC Filing  
5/26/2016Elaine UllianDirectorSell6,896$33.85$233,429.60View SEC Filing  
5/26/2016Karleen Marie ObertonVPSell4,228$33.85$143,117.80View SEC Filing  
2/24/2016David R Lavance JrDirectorSell11,621$34.50$400,924.50View SEC Filing  
11/10/2015Lawrence M. LevyDirectorSell20,000$40.70$814,000.00View SEC Filing  
9/21/2015Lawrence M. LevyDirectorSell5,000$42.02$210,100.00View SEC Filing  
9/8/2015Wayne WilsonDirectorSell100,000$39.00$3,900,000.00View SEC Filing  
8/28/2015Wayne WilsonDirectorSell11,146$39.70$442,496.20View SEC Filing  
8/26/2015Wayne WilsonDirectorSell25,080$38.61$968,338.80View SEC Filing  
8/14/2015Wayne WilsonDirectorSell13,257$42.20$559,445.40View SEC Filing  
6/3/2015Lawrence M LevyDirectorSell10,000$36.45$364,500.00View SEC Filing  
5/22/2015Lawrence M LevyDirectorSell5,000$35.05$175,250.00View SEC Filing  
5/4/2015Lawrence M LevyDirectorSell10,000$34.36$343,600.00View SEC Filing  
3/6/2015David R Lavance JrDirectorSell12,000$32.12$385,440.00View SEC Filing  
2/13/2015David R Lavance JrDirectorSell8,000$30.32$242,560.00View SEC Filing  
1/29/2015Karleen Marie ObertonVPSell18,997$30.00$569,910.00View SEC Filing  
11/11/2014Karleen Marie ObertonVPSell2,609$26.30$68,616.70View SEC Filing  
11/3/2014Karleen Marie ObertonVPSell12,507$26.83$335,562.81View SEC Filing  
10/31/2014Roger D MillsSVPSell14,506$26.00$377,156.00View SEC Filing  
9/9/2014Elaine UllianDirectorBuy7,900$25.36$200,344.00View SEC Filing  
5/9/2014Rohan HastieSVPSell6,037$24.36$147,061.32View SEC Filing  
5/8/2014Glenn MuirCFOSell50,000$24.26$1,213,000.00View SEC Filing  
5/6/2014Glenn MuirCFOSell196,000$23.29$4,564,840.00View SEC Filing  
5/6/2014Lawrence LevyDirectorSell5,052$23.58$119,126.16View SEC Filing  
5/6/2014Robert LavalleeCAOSell22,796$23.58$537,529.68View SEC Filing  
3/14/2014David Lavance, Jr.DirectorSell5,500$21.49$118,195.00View SEC Filing  
3/14/2014Glenn MuirCFOSell160,000$21.51$3,441,600.00View SEC Filing  
3/7/2014Mark CaseyCAOSell3,251$22.53$73,245.03View SEC Filing  
2/11/2014Stephen MacmillanCEOBuy38,600$21.58$832,988.00View SEC Filing  
2/7/2014Stephen MacmillanCEOBuy198,900$20.78$4,133,142.00View SEC Filing  
12/13/2013Robert LavalleeCAOSell15,677$21.70$340,190.90View SEC Filing  
10/30/2013Glenn P MuirCFOSell140,000$22.32$3,124,800.00View SEC Filing  
10/15/2013Glenn P MuirCFOSell28,000$22.12$619,360.00View SEC Filing  
9/16/2013Glenn MuirCFOSell28,000$20.45$572,600.00View SEC Filing  
9/13/2013Robert LavalleeCAOSell2,500$20.33$50,825.00View SEC Filing  
8/20/2013David BradySVPSell42,328$22.80$965,078.40View SEC Filing  
8/15/2013Glenn MuirCFOSell28,000$22.49$629,720.00View SEC Filing  
8/8/2013Lawrence LevyDirectorSell5,000$22.50$112,500.00View SEC Filing  
8/8/2013Mark CaseyCAOSell14,804$22.57$334,126.28View SEC Filing  
7/19/2013Robert H LavalleeCAOSell11,254$20.89$235,096.06View SEC Filing  
7/15/2013Glenn P MuirCFOSell28,000$19.78$553,840.00View SEC Filing  
7/1/2013Robert CascellaCEOSell20,000$19.55$391,000.00View SEC Filing  
6/17/2013Glenn P MuirCFOSell28,000$21.42$599,760.00View SEC Filing  
6/3/2013Robert CascellaCEOSell20,000$20.71$414,200.00View SEC Filing  
2/25/2013Lawrence M LevyDirectorSell5,000$22.00$110,000.00View SEC Filing  
9/5/2012Glenn P MuirCFOSell68,750$19.96$1,372,250.00View SEC Filing  
8/8/2012Glenn P MuirCFOSell68,750$19.69$1,353,687.50View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Hologic (NASDAQ:HOLX)
Latest Headlines for Hologic (NASDAQ:HOLX)
finance.yahoo.com logoHalyard Health (HYH) Expands CORGRIP System Product Line
finance.yahoo.com - May 23 at 5:19 PM
americanbankingnews.com logoHologic, Inc. (HOLX) Downgraded by Zacks Investment Research to "Hold"
www.americanbankingnews.com - May 23 at 1:52 PM
americanbankingnews.com logoInsider Selling: Hologic, Inc. (HOLX) Director Sells 9,076 Shares of Stock
www.americanbankingnews.com - May 19 at 10:22 AM
finance.yahoo.com logoMazor Robotics at a 52-Week High: What's Driving the Stock?
finance.yahoo.com - May 19 at 10:15 AM
streetinsider.com logoHologic (HOLX) Appoints Charles Dockendorff to Board - StreetInsider.com
www.streetinsider.com - May 17 at 5:42 PM
streetinsider.com logoHologic (HOLX) Appoints Charles Dockendorff to Board - StreetInsider.com
www.streetinsider.com - May 17 at 5:42 PM
finance.yahoo.com logoEaton Vance Worldwide Health Sciences Fund Adds 4 Companies
finance.yahoo.com - May 17 at 5:42 PM
finance.yahoo.com logoEaton Vance Worldwide Health Sciences Fund Adds 4 Companies
finance.yahoo.com - May 17 at 5:42 PM
finance.yahoo.com logoBlog Coverage: Boston Scientific Completes Symetis Acquisition; Views TAVI Portfolio Expansion through the Agreement
finance.yahoo.com - May 17 at 10:09 AM
finance.yahoo.com logoEdwards Lifesciences SAPIEN 3 Heart Valve Data Positive
finance.yahoo.com - May 17 at 10:09 AM
finance.yahoo.com logoGenomic Health Q1 Results Weak, Cancer Test Business Strong
finance.yahoo.com - May 17 at 10:09 AM
finance.yahoo.com logoAbbott Lab Well Poised on Strong EPD, St. Jude Integration
finance.yahoo.com - May 17 at 10:09 AM
finance.yahoo.com logoBoston Scientific Hits a 52-Week High on Solid Prospects
finance.yahoo.com - May 17 at 10:09 AM
streetinsider.com logoHologic (HOLX) Appoints Charles Dockendorff to Board
www.streetinsider.com - May 16 at 10:39 PM
finance.yahoo.com logoHologic, Inc. – Value Analysis (NASDAQ:HOLX) : May 16, 2017
finance.yahoo.com - May 16 at 5:37 PM
finance.yahoo.com logoCharles J. Dockendorff Elected to Hologic Board of Directors
finance.yahoo.com - May 16 at 5:37 PM
zacks.com logoEvolent Health (EVH) Prices 7M Follow-On Share Offering
www.zacks.com - May 16 at 11:18 AM
finance.yahoo.com logoHologic, Inc. breached its 50 day moving average in a Bearish Manner : HOLX-US : May 15, 2017
finance.yahoo.com - May 15 at 11:04 AM
americanbankingnews.com logoBrokers Set Expectations for Hologic, Inc.'s FY2017 Earnings (HOLX)
www.americanbankingnews.com - May 15 at 8:43 AM
americanbankingnews.com logoJefferies Group Weighs in on Hologic, Inc.'s Q3 2017 Earnings (HOLX)
www.americanbankingnews.com - May 15 at 8:14 AM
americanbankingnews.com logoHologic's (HOLX) "Buy" Rating Reiterated at BTIG Research
www.americanbankingnews.com - May 14 at 4:00 PM
nasdaq.com logoHologic (HOLX) Tops Q2 Earnings & Sales, Raises 2017 View - Nasdaq
www.nasdaq.com - May 12 at 11:25 PM
americanbankingnews.com logoResearch Analysts Set Expectations for Hologic, Inc.'s FY2018 Earnings (HOLX)
www.americanbankingnews.com - May 12 at 5:32 PM
americanbankingnews.com logoFY2017 EPS Estimates for Hologic, Inc. Increased by Leerink Swann (HOLX)
www.americanbankingnews.com - May 12 at 12:52 PM
americanbankingnews.com logoInsider Selling: Hologic, Inc. (HOLX) Director Sells 9,837 Shares of Stock
www.americanbankingnews.com - May 12 at 10:16 AM
finance.yahoo.com logoVarian ProBeam Proton System Gets Okayed by Shonin in Japan
finance.yahoo.com - May 11 at 6:17 PM
finance.yahoo.com logoHologic (HOLX) Tops Q2 Earnings & Sales, Raises 2017 View
finance.yahoo.com - May 11 at 6:17 PM
finance.yahoo.com logoMerck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers
finance.yahoo.com - May 11 at 6:17 PM
finance.yahoo.com logoKahn Brothers Sells Hologic, Pfizer, Citigroup
finance.yahoo.com - May 11 at 6:17 PM
finance.yahoo.com logoHologic Topples On 'Blip' In Breast Health, Body-Sculpting Unit
finance.yahoo.com - May 11 at 6:17 PM
americanbankingnews.com logoStifel Nicolaus Increases Hologic, Inc. (HOLX) Price Target to $48.00
www.americanbankingnews.com - May 11 at 8:26 AM
americanbankingnews.com logoHologic, Inc. (HOLX) Short Interest Up 25.2% in April
www.americanbankingnews.com - May 11 at 7:12 AM
finance.yahoo.com logoEdited Transcript of HOLX earnings conference call or presentation 10-May-17 8:30pm GMT
finance.yahoo.com - May 11 at 5:58 AM
americanbankingnews.com logoHologic, Inc. (HOLX) Announces Earnings Results
www.americanbankingnews.com - May 11 at 12:27 AM
seekingalpha.com logoHologic (HOLX) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 11:37 PM
nasdaq.com logoHologic Updates 2017 Guidance - Quick Facts
www.nasdaq.com - May 10 at 6:35 PM
finance.yahoo.com logoHologic Announces Financial Results for Second Quarter of Fiscal 2017
finance.yahoo.com - May 10 at 6:35 PM
finance.yahoo.com logoHologic tops Street 2Q forecasts
finance.yahoo.com - May 10 at 6:35 PM
americanbankingnews.com logoHologic, Inc. (HOLX) Issues FY17 Earnings Guidance
www.americanbankingnews.com - May 10 at 5:42 PM
americanbankingnews.com logoHologic, Inc. (HOLX) Issues Q3 Earnings Guidance
www.americanbankingnews.com - May 10 at 5:42 PM
finance.yahoo.com logoInvestor Network: Hologic, Inc. to Host Earnings Call
finance.yahoo.com - May 10 at 1:34 PM
americanbankingnews.com logoHologic, Inc. (HOLX) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - May 9 at 11:16 AM
americanbankingnews.com logo$0.46 EPS Expected for Hologic, Inc. (HOLX) This Quarter
www.americanbankingnews.com - May 9 at 8:10 AM
americanbankingnews.com logoHologic, Inc. (HOLX) Director Lawrence M. Levy Sells 10,203 Shares
www.americanbankingnews.com - May 5 at 8:11 PM
finance.yahoo.com logoAllscripts (MDRX) Beats on Q1 Earnings, Revenues In Line
finance.yahoo.com - May 5 at 4:17 PM
finance.yahoo.com logoIs a Surprise in Store for Hologic (HOLX) in Q2 Earnings? - Yahoo Finance
finance.yahoo.com - May 2 at 4:12 PM
finance.yahoo.com logoLuminex (LMNX) Tops Q1 Earnings, Revenue Guidance Raised
finance.yahoo.com - May 2 at 10:12 AM
finance.yahoo.com logoIs a Surprise in Store for Hologic (HOLX) in Q2 Earnings?
finance.yahoo.com - May 1 at 6:31 PM
nasdaq.com logoIs a Surprise in Store for Hologic (HOLX) in Q2 Earnings? - Nasdaq
www.nasdaq.com - May 1 at 1:30 PM
americanbankingnews.com logoHologic (HOLX) Receiving Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - April 29 at 9:15 PM



Hologic (HOLX) Chart for Friday, May, 26, 2017

This page was last updated on 5/26/2017 by MarketBeat.com Staff